CClinicalTrials.gg
Active, not recruitingNCT07105618Updated Aug 24, 2026

Total Intravenous Anesthesia in Patients Undergoing Craniotomy

An interventional study of Dexmedetomidine and Fentanyl in Anesthesia, sponsored by Zagazig University. Active, not recruiting at 1 site in Egypt. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-08-24.

Sponsored by Zagazig University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
All
01

Study summary

Craniotomy presents true anesthetic challenges, mainly due to the need to optimize cerebral perfusion, facilitate brain relaxation, achieve rapid emergence for neurologic assessment, and minimize perioperative complications.

Read the detailed description

Total intravenous anesthesia, particularly with propofol-based regimens, has gained favor in neurosurgical procedures for its neuroprotective properties, and reduced intracranial pressure; however, the choice of adjunct agents in total intravenous anesthesia remains a subject of ongoing investigation, especially regarding their influence on hemodynamic stability, analgesia, brain relaxation, and postoperative outcomes.

Total intravenous anesthesia techniques for craniotomy allow rapid recovery and stable hemodynamic parameters, so they decrease the hospital stay. The current study will compare the efficacy and safety profiles of dexmedetomidine, fentanyl, and magnesium sulfate as adjuncts in total intravenous anesthesia for patients undergoing craniotomy.

02

Conditions studied

  • Anesthesia
03

In context

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient acceptance.
  • Physical status: American Society of Anesthesiologists Physical Status (ASA) 1\& II.
  • Body mass index ≤ 30 kg/m2.
  • Type of operation: elective craniotomy for brain tumor resection.
  • Duration of surgery: within 4 hours.

Exclusion criteria

Exclusion Criteria:

  • Patient with hemodynamic instability or anticipated postoperative mechanical ventilation.
  • Patients with a known history of allergy to the study drugs.
  • Advanced hepatic, renal, cardiovascular, and neurologic diseases.
  • Patients with chronic opioid use.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    Dexmedetomidine group

    Intravenous loading dose of dexmedetomidine 1 µg/kg over 10 minutes before propofol infusion, followed by an intraoperative maintenance infusion of 0.5 µg/kg/hour.

    Drug: Dexmedetomidine

  • Active comparator
    Fentanyl group

    Intravenous loading dose of fentanyl 1 µg/kg over 10 minutes before propofol infusion, followed by an intraoperative maintenance infusion of 0.5 µg/kg/hour.

    Drug: Fentanyl

  • Active comparator
    Magnesium group

    Magnesium sulphate 30-50 mg/kg intravenous over 15-30 minutes before propofol infusion, followed by intraoperative maintenance infusion of 10-20 mg/kg/hour.

    Drug: Magnesium

Interventions

  • DrugDexmedetomidine

    Dexmedetomidine as an adjunct to total intravenous anesthesia.

    Also known as: Precedex

  • DrugFentanyl

    Fentanyl as an adjunct to total intravenous anesthesia.

  • DrugMagnesium

    Magnesium sulphate as an adjunct to total intravenous anesthesia.

    Also known as: Magnesium sulphate

06

What researchers measure

Primary outcomes

  1. The total intraoperative propofol consumption

    The total intraoperative propofol consumption (in milligrams).

    Time frame: 4 hours

Secondary outcomes

  1. Intraoperative heart rate

    Monitoring the changes in heart rate intraoperative.

    Time frame: 4 hours

  2. Intraoperative mean arterial pressure

    Monitoring the changes in mean arterial pressure intraoperative.

    Time frame: 4 hours

  3. Brain relaxation score

    Evaluating the brain relaxation right after the dura is opened using a scale from 1 to 4 (1 = perfectly relaxed, 2 = satisfactorily relaxed, 3 = firm brain, 4 = bulging brain).

    Time frame: 4 hours

  4. Additional doses of intraoperative fentanyl.

    The total number of patients requiring additional dose of intraoperative fentanyl.

    Time frame: 4 hours

  5. The time to first request for rescue analgesia

    The time to first request for rescue analgesia in first 24 hour.

    Time frame: The first 24 hours postoperative.

  6. Postoperative pain assessment

    Postoperative pain assessment by the numeric rating scale in the recovery room and at 2,4,8,16 and 24 hours after surgery.

    Time frame: The first 24 hours postoperative.

07

Study locations

1 site
  • Zagazig university hospital
    Zagazig, Egypt
08

References and documents

Publications

  • Ali AR, El Ghoneimy MN. Dexmedetomidine versus fentanyl as adjuvant to propofol: comparative study in children undergoing extracorporeal shock wave lithotripsy. Eur J Anaesthesiol. 2010 Dec;27(12):1058-64. doi: 10.1097/EJA.0b013e32833e6e2d. PubMed 20805754 ↗
  • Telci L, Esen F, Akcora D, Erden T, Canbolat AT, Akpir K. Evaluation of effects of magnesium sulphate in reducing intraoperative anaesthetic requirements. Br J Anaesth. 2002 Oct;89(4):594-8. doi: 10.1093/bja/aef238. PubMed 12393361 ↗
  • Chandar Chinnarasan V, Bidkar PU, Swaminathan S, Mani M, Vairappan B, Chatterjee P, Joy JJ, Dey A, Ramadurai R, Gunasekaran A. Comparison of dexmedetomidine versus fentanyl-based total intravenous anesthesia technique on the requirement of propofol, brain relaxation, intracranial pressure, neuronal injury, and hemodynamic parameters in patients with acute traumatic subdural hematoma undergoing emergency craniotomy: A randomized controlled trial. Surg Neurol Int. 2024 Dec 13;15:462. doi: 10.25259/SNI_892_2024. eCollection 2024. PubMed 39777171 ↗
  • Preethi J, Bidkar PU, Cherian A, Dey A, Srinivasan S, Adinarayanan S, Ramesh AS. Comparison of total intravenous anesthesia vs. inhalational anesthesia on brain relaxation, intracranial pressure, and hemodynamics in patients with acute subdural hematoma undergoing emergency craniotomy: a randomized control trial. Eur J Trauma Emerg Surg. 2021 Jun;47(3):831-837. doi: 10.1007/s00068-019-01249-4. Epub 2019 Oct 29. PubMed 31664468 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07105618
Lead sponsor
Zagazig University
Responsible party
Sponsor
First posted
Aug 6, 2025
Start date
Aug 10, 2025
Primary completion
May 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Aug 24, 2026

Study contacts

Fatma Mahmoud Ahmed, MD
principal investigator · Department of Anesthesia, Intensive Care & Pain Management, Zagazig University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion